trial summary · NCT07630155
Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma
A Prospective Clinical Assessment of Office-Based Ureteroscopy for Upper Tract Urothelial Carcinoma Utilizing a 6.3 French Single Use Digital Flexible Ureteroscope
Trial record from the TrialBase DB dataset, status RECRUITING, condition Renal Pelvis and Ureter Urothelial Carcinoma, sponsored by University of Michigan Rogel Cancer Center. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This clinical trial tests how well office based ureteroscopy utilizing a single use digital, flexible ureteroscope works for the assessment of upper tract urothelial carcinoma. Ureteroscopy is a procedure in which a thin camera called a ureteroscope is used to assess patients with a known or suspected diagnosis of upper tract urothelial carcinoma. Ureteroscopy is traditionally performed in an operating room under general anesthesia. In this study, patients undergo ureteroscopy in the doctor's office using an ultra-thin ureteroscope, which is the narrowest instrument of its kind. Because of its small size, researchers believe this procedure can be completed in the office with minimal discomfort and high patient satisfaction, which may eliminate the risks of general anesthesia and reduce delays to diagnosis. Office based ureteroscopy utilizing a single use digital, flexible ureteroscope may be effective for the assessment of upper tract urothelial carcinoma.
Source record: https://clinicaltrials.gov/study/NCT07630155
Facts
| registry id | NCT07630155 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Renal Pelvis and Ureter Urothelial Carcinoma |
| sponsor | University of Michigan Rogel Cancer Center |
| sponsor class | OTHER |
| enrollment | 10 |
| start date | 2026-12 |
| primary completion | 2027-12 |
| completion | 2027-12 |
| results posted | not reported |
Conditions
- Renal Pelvis and Ureter Urothelial Carcinoma
Interventions
- Analgesic Agent
- Electronic Health Record Review
- Lidocaine Topical
- Medical Device Usage and Evaluation
- Survey Administration
- Ureteroscopy
Countries
- United States
Intervention types: DEVICE, DRUG, OTHER, PROCEDURE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.